These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 30425061)

  • 21. Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy.
    Yuan H; Reddy MA; Deshpande S; Jia Y; Park JT; Lanting LL; Jin W; Kato M; Xu ZG; Das S; Natarajan R
    Antioxid Redox Signal; 2016 Mar; 24(7):361-75. PubMed ID: 26492974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys.
    Gong W; Chen Z; Zou Y; Zhang L; Huang J; Liu P; Huang H
    Free Radic Biol Med; 2018 Feb; 115():338-350. PubMed ID: 29248720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Nampt-Sirt6 Axis in Renal Proximal Tubules in Extracellular Matrix Deposition in Diabetic Nephropathy.
    Muraoka H; Hasegawa K; Sakamaki Y; Minakuchi H; Kawaguchi T; Yasuda I; Kanda T; Tokuyama H; Wakino S; Itoh H
    Cell Rep; 2019 Apr; 27(1):199-212.e5. PubMed ID: 30943401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
    McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
    Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An aqueous extract of Portulaca oleracea ameliorates diabetic nephropathy through suppression of renal fibrosis and inflammation in diabetic db/db mice.
    Lee AS; Lee YJ; Lee SM; Yoon JJ; Kim JS; Kang DG; Lee HS
    Am J Chin Med; 2012; 40(3):495-510. PubMed ID: 22745066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-27a promotes renal tubulointerstitial fibrosis via suppressing PPARγ pathway in diabetic nephropathy.
    Hou X; Tian J; Geng J; Li X; Tang X; Zhang J; Bai X
    Oncotarget; 2016 Jul; 7(30):47760-47776. PubMed ID: 27351287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease.
    Li Y; Hu Q; Li C; Liang K; Xiang Y; Hsiao H; Nguyen TK; Park PK; Egranov SD; Ambati CR; Putluri N; Hawke DH; Han L; Hung MC; Danesh FR; Yang L; Lin C
    J Clin Invest; 2019 Mar; 129(3):1129-1151. PubMed ID: 30741721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.
    Oguiza A; Recio C; Lazaro I; Mallavia B; Blanco J; Egido J; Gomez-Guerrero C
    Diabetologia; 2015 Jul; 58(7):1656-67. PubMed ID: 25982245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
    Li Z; Hong Z; Peng Z; Zhao Y; Shao R
    Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN; LaPage J; Hirschberg R
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of EphA1-Epha receptor axis attenuates diabetic nephropathy in mice.
    Li Y; Yan H; Wang F; Huang S; Zhang Y; Wang Z; Zhong M; Zhang W
    Biochem Biophys Res Commun; 2017 May; 486(3):693-699. PubMed ID: 28341121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy.
    Matsubara T; Araki M; Abe H; Ueda O; Jishage K; Mima A; Goto C; Tominaga T; Kinosaki M; Kishi S; Nagai K; Iehara N; Fukushima N; Kita T; Arai H; Doi T
    Diabetes; 2015 Aug; 64(8):2978-90. PubMed ID: 25995358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.
    Yang R; Xu X; Li H; Chen J; Xiang X; Dong Z; Zhang D
    Sci Rep; 2017 Feb; 7():43409. PubMed ID: 28240316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-β1-induced kidney injury in a mouse model of diabetes.
    Lo CS; Shi Y; Chang SY; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Diabetologia; 2015 Oct; 58(10):2443-54. PubMed ID: 26232095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility.
    Tan SM; Ziemann M; Thallas-Bonke V; Snelson M; Kumar V; Laskowski A; Nguyen TV; Huynh K; Clarke MV; Libianto R; Baker ST; Skene A; Power DA; MacIsaac RJ; Henstridge DC; Wetsel RA; El-Osta A; Meikle PJ; Wilson SG; Forbes JM; Cooper ME; Ekinci EI; Woodruff TM; Coughlan MT
    Diabetes; 2020 Jan; 69(1):83-98. PubMed ID: 31624141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats.
    Hill C; Flyvbjerg A; Grønbaek H; Petrik J; Hill DJ; Thomas CR; Sheppard MC; Logan A
    Endocrinology; 2000 Mar; 141(3):1196-208. PubMed ID: 10698197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
    Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
    Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation.
    Luan P; Zhuang J; Zou J; Li H; Shuai P; Xu X; Zhao Y; Kou W; Ji S; Peng A; Xu Y; Su Q; Jian W; Peng W
    FASEB J; 2018 Feb; 32(2):1070-1084. PubMed ID: 29070585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.